About Hua Medicine


Phase 1

Phase 2 Phase 3

HMS5552 (glucokinase activator)

Type 2 Diabetes

mGluR5 NAM
PD-LID/Depression/other CNS indications

Hua Medicine is a leading clinical-stage, innovative drug development company in China, focusing on novel therapies for the treatment of diabetes and CNS disorders.

In order to meet the highest international standards, Hua Medince developed a powerful internal research quality supervision system Q (QC/QA) based on the advanced open innovation model VIC (VC + IP + CRO).